Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.
Press releases published on June 5, 2025
Doheny Eye Institute Welcomes Emma Lessieur-Contreras, MD, PhD, as Principal Investigator
GlobeNewswire
·
June 5, 2025
PASADENA, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions for more than 75 years, is adding to its panel of remarkable vision scientists with the appointment of Emma Lessieur- …
Precision Optics Expands Facilities to Meet Growing Backlog
GlobeNewswire
·
June 5, 2025
Company signs lease to move corporate offices and engineering development to Littleton, MA Move allows for expansion of production capabilities in Gardner, MA to meet increased backlog GARDNER, Mass. and LITTLETON, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- …
Cellectar Biosciences Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules
GlobeNewswire
·
June 5, 2025
FLORHAM PARK, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the entry into …
Norwegian Cruise Line Holdings Releases Its 2024 “Sail & Sustain™” Report
GlobeNewswire
·
June 5, 2025
MIAMI, June 05, 2025 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH), a leading global cruise company operating Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises, today released its 2024 Sail …
SELLAS Life Sciences Expands Scientific Advisory Board with Addition of Two World-Renowned Hematology and Oncology Experts
GlobeNewswire
·
June 5, 2025
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
Omega Laboratories Delivers Marijuana Breath Test Validation Packet to Cannabix Technologies Inc. - Completing Major Milestone under Strategic Partnership
GlobeNewswire
·
June 5, 2025
VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports that Omega Laboratories Inc. of Ohio, USA (“Omega Laboratories” or “Omega”) a …
Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain
GlobeNewswire
·
June 5, 2025
Follow-on study (“PoC 2”) builds on initial success in pancreatic cancer pain Ethics committee authorization supports platform expansion into visceral cancer pain for proprietary ablation technology Expansion supports Autonomix’s strategy to build long- …
Tria Federal Promotes Atchut Kanthamani to President, Opens New Maryland Office
GlobeNewswire
·
June 5, 2025
ARLINGTON, Va., June 05, 2025 (GLOBE NEWSWIRE) -- Tria Federal has promoted Atchut Kanthamani to the new position of President. In this role, he will lead Tria's business growth and technology innovation teams. Kanthamani, the founder and CEO of Softrams, …
Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index
GlobeNewswire
·
June 5, 2025
HINGHAM, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced that it has been selected for inclusion in the preliminary list of additions to the Russell …
TOMI Announces Appointment of David Vanston as Chief Financial Officer
GlobeNewswire
·
June 5, 2025
FREDERICK, Md., June 05, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced the appointment of Mr. David Vanston as Chief …
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the 2025 European Hematology Association (EHA) Annual Meeting
GlobeNewswire
·
June 5, 2025
– Company to showcase preclinical studies of ARV-393, an investigational oral PROTAC BCL6 degrader, as a single agent in models of nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (AITL) and transformed follicular lymphoma, and in …
Biomerica’s inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology
GlobeNewswire
·
June 5, 2025
Landmark Peer-Reviewed Study Demonstrates Effectiveness of Personalized Dietary Therapy for IBS Patients Using inFoods® IBS Test. Gastroenterology, the premier journal in gastrointestinal science, features data supporting inFoods IBS as an effective …
Dr. Allison Fleming of Align Chiropractic Shares Why Core Strength Is Essential for a Healthy Spine in HelloNation Magazine
GlobeNewswire
·
June 5, 2025
ROCHESTER, N.Y., June 05, 2025 (GLOBE NEWSWIRE) -- What is the missing link between spinal health and daily movement that many people overlook? Dr. Allison Fleming of Align Chiropractic in Rochester, New York, explains that it often comes down to one thing …
Kristy Weems of Fyzical in Douglas, GA Emphasizes Why Early Physical Therapy Matters in HelloNation Magazine
GlobeNewswire
·
June 5, 2025
DOUGLAS, Ga., June 05, 2025 (GLOBE NEWSWIRE) -- When is the right time to begin physical therapy? Kristy Weems of Fyzical in Douglas, Georgia, explains that the answer is often sooner than people think. In HelloNation Magazine, Weems highlights why early …
Ear Nose and Throat Clinic of Coffee County’s Dr. George Livermore Shares Insights as Sinus Pain Relief Expert in HelloNation Magazine
GlobeNewswire
·
June 5, 2025
DOUGLAS, Ga., June 05, 2025 (GLOBE NEWSWIRE) -- What should individuals do when seasonal congestion becomes more than just an occasional nuisance? According to Dr. George Livermore of the Ear Nose and Throat Clinic of Coffee County, recognizing the signs …
DIOSynVax Presents Its Technology at the Invitation-Only Next Venture Capital Unit (VCU) Health Tech Showcase at the London Stock Exchange
GlobeNewswire
·
June 5, 2025
CAMBRIDGE, United Kingdom and SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- DIOSynVax, a clinical-stage biotechnology company at the forefront of developing safe, innovative, broadly protective vaccines presented its unique broad-based vaccine technology at …
Nanox Receives MDR CE Mark for HealthOST, an Advanced AI-Powered Software for Spine Assessment
GlobeNewswire
·
June 5, 2025
HealthOST identifies vertebral height loss and bone mineral density, which are key indicators of musculoskeletal disease Osteoporosis is a common progressive bone disease among adults over 50 years of age that causes bones to weaken, leading to fractures …
Teladoc Health to Participate in Upcoming Investor Conference
GlobeNewswire
·
June 5, 2025
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the Goldman Sachs …
Reviva to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
GlobeNewswire
·
June 5, 2025
CUPERTINO, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 5, 2025
BRISBANE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards …